THE NOTCH SIGNALING PATHWAY plays a key role in self-renewal of intestinal epithelial cells and their allocation to specific differentiation lineages (37) . The core pathway is composed of relatively few components (30) . Ligand activation results in two proteolytic cleavage events in the transmembrane domain of the Notch receptor, leading ultimately to the release of the activated form of the receptor as the Notch intracellular domain (NICD) (3, 8) . In the nucleus, NICD interacts with the DNAbinding protein CSL [RBP-J; CBF1, Su(H), and Lag-1] to regulate expression of downstream genes such as the hairy and enhancer of split (Hes) gene and Hey family members (11) . Hes-1 is a basic helix-loop-helix transcriptional repressor induced by the Notch signal, while mouse atonal homolog 1 (Math-1) (11) is another basic helix-loop-helix transcription factor that is repressed by Hes-1. Deregulated Notch signaling correlates with cancer, as exemplified in T-cell lymphoblastic leukemia, where the majority of patients carry mutations in Notch 1 (43) , and in breast cancer, where expression of the activated form of Notch is elevated (35) . Similarly, NF-B is ubiquitously expressed in most cell types and regulates a variety of genes responsible for immune function and inflammation (22) . NF-B is considered crucial in maintaining intestinal inflammation during host defense (22) , and a high level of activation is thought to be a causative factor in the development of colitis and chronic inflammatory bowel disease (IBD) (20, 23) . Thus NF-B has become a potential therapeutic target in the control of chronic intestinal inflammation.
There are numerous reports describing regulation of NF-B by Notch, and vice versa (25) . Bash et al. (5) reported transcriptional upregulation of the Notch ligand Jagged-1 by NF-B in B cells. Similarly, Guan et al. (14) reported that ectopically overexpressed NICD has an IB-like activity in Jurkat cells. In another report, upregulation of NF-B by Notch was described. Similarly, Notch-1 transactivates the promoter of p52, a member of the NF-B family (26) . In cancer biology, Notch and NF-B are prominent therapeutic targets. If murine and in vitro data could be extrapolated to humans, treatment of cancers dependent on Notch activity may benefit from combinations of agents targeting both pathways, for example, inhibiting Notch and IB kinase activities or Notch and the proteasome. This notion is supported by evidence that some cancers in which Notch plays a clearly oncogenic role, such as breast and pancreatic carcinomas, are also often characterized by high NF-B activity. In a large series of cervical cancer specimens, Ramdass et al. (28) showed that NF-B and Notch pathways were commonly coactivated, as judged by expression of Notch and NF-B target genes and nuclear localization of NF-B immunoreactivity. In the intestine, however, little is known regarding the existence of such cross talks and how they are regulated. Previously, in transgenic mice overexpressing progastrin, a potent mitogen, we showed that functional cross talk exists between ␤-catenin and NF-B in the colonic crypts and that pathways that dictate goblet cell lineage, such as Notch, may be downstream from NF-B/␤-catenin activation (39) . In an in vivo murine model, we showed that a functional cross talk between Wnt/␤-catenin and Notch pathways regulates colonic crypt hyperplasia and/or colitis in response to an enteric pathogen (1) . In the current study, we aimed to investigate the interplay between the Notch and NF-B pathways and how they regulate hyperplasia, inflammation, or carcinogenesis following bacterial infection.
Citrobacter rodentium (CR) is a gram-negative, noninvasive bacterial pathogen that infects the distal colon of mice and causes transmissible murine colonic hyperplasia (TMCH), which is accompanied by expansion of the proliferative compartment throughout the longitudinal crypt axis (38) . It belongs to the family of attaching and effacing (A/E) bacterial pathogens, including enteropathogenic and enterohemorrhagic Escherichia coli (21) , which cause debilitating disease, especially among infants and children, and are a threat to global health. As enteropathogenic and enterohemorrhagic E. coli are poorly pathogenic to mice, CR infection has been regarded as a surrogate for the study of inflammatory conditions that mimic human IBDs (6, 7, 27) . Interestingly, unlike human conditions, TMCH is self-limiting, leading to disease resolution and protective immunity.
Utilizing the TMCH model, we provide experimental evidence that a functional cross talk exists between Notch and NF-B pathways in various genetic strains in response to CR infection and that NF-B signaling is downstream from Notch in colonic crypts. We also examined the mechanistic basis of colitis in NIH Swiss mice in the aftermath of chronic Notch inhibition and how dietary intervention modulates NF-B activity in the crypts and crypt-denuded lamina propria (CLP) to affect expression of proinflammatory cytokines and chemokines.
MATERIALS AND METHODS
Mice. Male Helicobacter pylori-free NIH Swiss mice were procured from Harlan Laboratories. Core-3 Ϫ/Ϫ mice lacking core-3 ␤-1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predicted to be important in the synthesis of core-3-derived O-glycans, against a mixed-background strain of C57BL/6J mice were generated as described elsewhere (2) . Disruption of the C3GnT gene eliminates core-3-derived O-glycans, which are the primary components of the intestinal mucous layer that overlies the gastrointestinal epithelium. Core-3 Ϫ/Ϫ mice are highly susceptible to experimental triggers of colitis and colorectal adenocarcinoma (2) . Recombinant-activating gene-1-deficient (Rag-1 Ϫ/Ϫ ) mice lacking mature B and T cells (stock no. 002216) in the C57BL/6J background were purchased from Jackson Laboratory. The use of core-3 Ϫ/Ϫ and Rag-1 Ϫ/Ϫ mice was necessary to assess the effect of various genetic manipulations on Notch-NF-B cross talk in vivo in response to CR infection. All the mice were maintained in a specific pathogen-free (including Helicobacter and Parvovirus) environment and generally used between 5 and 6 wk of age. As control groups, littermates or wild-type mice of identical background were used. This study was carried out in strict accordance with the recommendations in the National Institutes of Health Guide for the Care (9, 10, 29, 32, 33, 38, 42) . Biotype 4280 is a unique mousespecific strain that adheres to mature surface colonocytes within the distal colon to induce histopathological changes known as A/E lesions (4). Adherent bacteria were assayed using RT-PCR for bacterial intimin in whole tissue extracts (38) . Age-and sex-matched control mice received sterile culture medium only. To block Notch signaling in vivo, we used a cell-permeable inhibitor of ␥-secretase, dibenzazepine (DBZ; EMD Chemicals, Gibbstown, NJ) (18) . DBZ was suspended finely in 0.5% (wt/vol) hydroxymethylpropylcellulose and 0.1% (wt/vol) Tween 80 in water and administered to mice (10 mol/kg body wt ip) acutely for 5 consecutive days beginning 1 or 7 days after CR infection or chronically for 10 consecutive days beginning 2 days after CR infection. For dietary intervention, mice were randomized to receive a control AIN-93 diet synthesized by Harlan Teklad (Madison, WI) or a 4% curcumin and/or 4% bael (Aegle marmelos) extract diet. All dietary interventions began 2 days after CR infection, as described previously (10, 38) . Animals were euthanized at 0, 6, and/or 12 days postinfection, and distal colons were removed to isolate crypts or CLP, as described elsewhere (9, 10, 29, 32, 33, 38, 42) .
Real-time PCR. Total RNA was isolated from crypts subjected to various regimens using TRIzol reagent. Expression levels of CXC chemokine ligand (CXCL)-1/keratinocyte-derived chemokine (KC) in the colonic crypts or CLP were measured by synthesis of cDNA from total RNA by SuperScript II reverse transcriptase and random primers (Invitrogen, Carlsbad, CA). cDNAs were then used for real-time PCR using Jumpstart Taq DNA polymerase (Sigma-Aldrich) and SYBR Green nucleic acid stain (Molecular Probes, Eugene, OR). Crossing threshold values for individual genes were normalized to GAPDH. Changes in mRNA expression are expressed as fold change relative to control. Primer sequences used for PCR are gene-specific and provided as follows: CXCL-1 [accession no. NM_008176; 5=-GCCAAT-GAGCTGCGCTGTCAATGC-3= (forward) and 5=-CTTGGGGA-CACCTTTTAGCATCTT-3= (reverse)] and GAPDH [accession no. NM_008084; 5=-AACTTTGGCATTGTGGAAGG-3= (forward) and 5=-ACACATTGGGGGTAGGAACA-3= (reverse)].
DNA-binding assay. For DNA-binding assay, relative levels of activated p65-NF-B in nuclear extracts prepared from uninfected, CR-infected, CR-infected ϩ DBZ-treated, and CR-infected ϩ DBZtreated ϩ diet-treated mouse distal colonic crypts or CLP were measured using the TransAm NF-B p65 transcription factor assay kit (Active Motif, Carlsbad, CA) according to the manufacturer's instructions.
Luciferase assay and NF-B-dependent reporter gene expression assay. For measurement of reporter activity, LipoD293 transfection reagent (Signagen Laboratories, Ijamsville, MD) was used to transfect young adult mouse colon cells with NF-B-luciferase (Luc) reporter plasmid [pGL4.32(luc2P/NF-B-RE/Hygro)] or pGL4.15 (luc2p/Hygro) vector as control (Promega, Madison, WI). At 24 h posttransfection, cells were infected with CR at multiplicity of infection (MOI) of 90 for 3 h. Cells were then washed to remove the bacteria and incubated at 37°C with or without DBZ (0.1 M) or 1-hydroxy-5,7-dimethoxy-2-naphthalene carboxaldehyde (HDNC, 10 M) for 24 and 48 h. Luciferase activity was measured using the Bright-Glo luciferase assay system (Promega). In another experiment, NF-Bdependent reporter gene expression was assayed using the NF-B/ SEAPorter assay kit (Imgenex, San Diego, CA). HEK-293 reporter cells were cultured in DMEM with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 10 g/ml blasticidin, and 500 g/ml G418 antibiotic. Cells were infected with CR at MOI of 90 for 3 h, washed, incubated in fresh medium, and treated with DBZ (0. CMV.GFP vector or EF.RFP vector alone for 6 h. The transfected cells were treated with or without CR for 3 h and washed to remove bacteria. After 48 h, the cells were processed for measurement of the relative levels of luciferase.
Western blotting. Total crypt cellular or nuclear extracts (30 -50 g protein/lane) were subjected to SDS-PAGE and electrotransferred to nitrocellulose membranes. The membranes were blocked with 5% BSA or 5% nonfat dry milk in Tris-buffered saline (20 mM Tris·HCl and 137 mM NaCl, pH 7.5) for 1 h at room temperature (21°C). Immunoantigenicity was detected by incubation of the membranes overnight with the appropriate primary antibodies (0.5-1.0 g/ml in 5% BSA or 5% nonfat dry milk). After they were washed, the membranes were incubated with horseradish peroxidase-conjugated anti-goat, anti-mouse, or anti-rabbit secondary antibodies and developed using enhanced chemiluminescence (ECL Detection System, GE) according to the manufacturer's instructions.
Histology and immunohistochemistry. For histology, tissues were fixed with 10% neutral buffered formalin or Carnoy's fixative (60% methanol, 30% chloroform, and 10% acetic acid) prior to paraffin embedding. Paraffin-embedded sections (5 m) were stained with hematoxylin-eosin for gross morphology and with Alcian blue to detect goblet cells. Images were obtained with an Eclipse E1000 microscope (Nikon). Immunohistochemistry (IHC) to detect p65 276 , CD3 ϩ T cells, and F4/80 ϩ macrophages was performed on 5-mthick paraffin-embedded sections prepared from distal colons of uninfected normal, CR-infected, or CR-infected and DBZ-treated mice utilizing the horseradish peroxidase (HRP)-labeled polymer conjugated to secondary antibody using the EnVisionϩ System-HRP (diaminobenzidine; DakoCytomation, Carpinteria, CA) with microwave accentuation, as described previously (42) . Antibody controls included omission of the primary antibody or detection of endogenous IgG staining with goat anti-mouse or anti-rabbit IgG (Calbiochem, San Diego, CA). Visualization was carried out using light microscopy. IHC data were graded on the basis of the percentage of stained cells showing a range of immunoreactivity as follows: Ͻ10%, 10 -30%, 30 -60%, or Ͼ60% of crypt epithelial/CLP cells stained positive. A minimum of ϳ200 crypts, or ϳ2,000 cells/field, were counted for each experimental group. For statistical analysis of the staining scores, Student's t-test was performed (see Statistical analysis).
Measurement of colonic cytokines/chemokines. For cytokine/ chemokine measurement, distal colons were collected from uninfected, CR-infected, and CR-infected and DBZ-treated NIH Swiss mice, washed with saline, and homogenized in PBS. Protein concentration was assessed using the DC protein assay kit (Bio-Rad). The cytokine/chemokine concentration in the colonic extracts was measured in triplicate by Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-Rad) according to the manufacturer's instructions.
Measurement of myeloperoxidase activity. Myeloperoxidase (MPO) activity, an index of neutrophil recruitment, was measured in colon tissue homogenates by a modification of the method of Grisham et al. (13) . Briefly, colon homogenate was sonicated in 1% hexadecyltrimethylammonium bromide buffer and centrifuged at 12,000 rpm at 4°C for 20 min. MPO activity in the homogenates was measured in triplicate using a fluorescent MPO detection kit (Fluoro MPO, Cell Technology) according to the manufacturer's instructions.
Statistical analysis. Experiments were repeated three times with consistent results. Values are means Ϯ SE. Statistical analyses for all studies were performed using unpaired two-tailed Student's t-tests and one-way ANOVA for multiple group comparisons (GraphPad Prism 5, San Diego, CA). P Ͻ 0.05 was considered statistically significant.
RESULTS
We recently showed that signaling via Notch and Wnt/␤-catenin pathways regulates progression (days 6 -12) and regression (days 20 -34) of colonic crypt hyperplasia following CR infection and that chronic inhibition of the Notch pathway interferes with the crypt regenerative process, leading to colitis (1). In the current study, we made an attempt to understand whether deregulated cross talk between the Notch and NF-B pathways in the crypt and CLP may have also contributed to disease pathogenesis in the aftermath of chronic Notch inhibition.
Acute blocking of the Notch pathway does not affect NF-B signaling. Infection with CR induced a predictable and reproducible hyperproliferation/hyperplasia in adult NIH Swiss mouse distal colon, with a significant increase in crypt length without an increase in mucosal inflammatory cell numbers, as shown previously (33) . During TMCH, relative changes in NF-B activity ( 276 antibody, we observed relatively few positive cells in the uninfected control ( Fig. 1G ). At day 6, and particularly at day 12, p65 276 staining increased significantly compared with control, as reported previously (9, 10, 29) , while DBZ treatment had no adverse effect on p65 276 staining (Fig. 1G ). Thus acute blocking of the Notch pathway before or after the onset of hyperplasia showed no inhibition of NF-B signaling.
Chronic blockade of Notch signaling inhibits crypt NF-B. Next, we investigated the effects of chronic Notch inhibition on NF-B activity after CR infection. With chronic DBZ- ), along with total p65, in colonic crypt extracts from groups described in A. F: cellular and nuclear ratios of p65 536 to total p65 vs. actin and lamin B. Values are means Ϯ SE; n ϭ 3 independent experiments. *P Ͻ 0.05 vs. N. G: paraffin-embedded sections from distal colons of groups described in A stained with antibody specific for p65 276 and analyzed using light microscopy. Values represent percentage of cells positive for p65 276 . Scale bars, 80 m.
induced Notch inhibition for 10 consecutive days, in addition to blockade of Notch signaling as reported earlier (1), we also observed significant inhibition of NF-B activity (Fig. 2Ai) , which led to concomitant decreases in CXCL-1 expression (Fig. 2Aii) . These changes were also associated with decreases in cellular and nuclear levels of p65 276 ( Fig. 2Bi) an enzyme important in the synthesis of core 3-derived Oglycans, the primary component of the intestinal mucins. We recently showed that chronic DBZ administration to these mice causes disruption of the intestinal barrier, leading to exacerbation of colitis (1) . When colonic crypts of DBZ-treated core-3 Ϫ/Ϫ mice were utilized for the measurement of NF-B activity, we observed a significant decrease (Fig. 2Ci) concomitant with almost complete inhibition of CXCL-1 expression (Fig.  2Cii) . Furthermore, decreases in relative levels of p65 276 ( Fig.  2Di ) and p65 536 (Fig. 2Dii ) correlated with the decreases in NF-B activity.
It has been shown previously that the multiple intestinal neoplasia (Min) mouse, which harbors a germ-line mutation in one of the alleles of the adenomatous polyposis coli (Apc) tumor suppressor gene, is a model for early stages of human colorectal cancer. Moreover, heterozygous Apc multiple intestinal neoplasia (Apc Min/ϩ ) mice have been shown to exhibit increased tumorigenesis in response to CR infection (24) . When 4-to 5-wk-old Apc Min/ϩ mice were infected with CR, significant hyperplasia was recorded at 10 days postinfection compared with uninfected controls, while tumors resembling adenomas developed in the distal colon of these mice at 3 mo of age (Fig. 3A) . These tumors were highly proliferative, as revealed by Ki-67 staining (Fig. 3B) , and also exhibited significant p65 276 immunoreactivity (Fig. 3C) . We next treated these mice with DBZ for 10 days starting at day 80. After the animals were euthanized, the tumors were examined for changes in p65 276 staining and Ki-67 labeling. Interestingly, 276 and p65 536 , along with total p65, in colonic crypt extracts from groups described in A. Ci: distal colonic crypt nuclear extracts prepared from groups treated as described in A. NF-B activity in core-3 Ϫ/Ϫ mice was determined by a DNAbinding assay. Values are means Ϯ SE; n ϭ 3 independent experiments. *P Ͻ 0.05 vs. N; **P Ͻ 0.05 vs. CR. Cii: expression of CXCL-1/KC mRNA isolated from colonic crypts of groups described in A measured via real-time PCR as a readout for NF-B activity. Values are means Ϯ SE; n ϭ 3 independent experiments. *P Ͻ 0.05 vs. N; **P Ͻ 0.05 vs. CR. Di and Dii: Western blots showing relative levels of cytosolic and nuclear p65 276 and p65 536 , along with total p65, in colonic crypt extracts from groups described in A. DBZ administration led to significant inhibition of Ki-67 labeling of the mutated crypts, perhaps due to decreases in p65 276 immunoreactivity (Fig. 3, B and C) . Thus, core-3
and Apc Min/ϩ mice exhibit Notch-NF-B cross talk similar to that recorded in NIH Swiss mice in response to CR infection.
In vitro approaches to validate Notch-NF-B cross talk. Notch-NF-B cross talk was further validated by in vitro reporter activities. As shown in Fig. 4A , young adult mouse colon cells transfected with NF-B reporter plasmid alone did not enhance NF-B activity, while CR infection for 3 h at MOI of 90 led to a significant increase in NF-B activity at 24 and 48 h postinfection. In response to DBZ, the reporter activity declined significantly at 24 h and declined further at 48 h. HDNC, with known anti-inflammatory properties (36) , was used as a control to ensure inhibition of NF-B activity (Fig.  4) . In another assay, we utilized a stably cotransfected HEK-293 cell line that expresses full-length TLR4 and the secreted alkaline phosphatase (SEAP) reporter gene under the transcriptional control of an NF-B response element (TLR4/NF-B/ SEAPorter, hereby designated the HEK-293 reporter cell line). When these cells were infected with CR, we observed a sequential increase in SEAP levels at 24, 48, and 72 h compared with uninfected control, while DBZ blocked increases in NF-B activity (Fig. 4B) . HDNC was again used as a control to ensure inhibition of NF-B activity (Fig. 4B) . Finally, in a proof-of-principle experiment, HEK-293 reporter cells were transfected with NICD-green fluorescent protein (GFP) or empty vector, and following infection with CR, cells expressing NICD-GFP exhibited a significant increase in NF-B activity compared with uninfected or empty-vector control cells (Fig. 4C) . These results unequivocally demonstrate cross talk between the Notch and NF-B pathways in response to CR infection.
CLP: the site of active inflammation. Since blocking Notch signaling chronically leads to severe inflammation and colitis, as reported by us recently (1), one would expect an exaggerated NF-B response in the gut. Inhibition of NF-B in the crypts, however, suggests that the stromal compartment comprising the lamina propria, and not the crypts, may be the site for active inflammation. We therefore isolated CLP from NIH Swiss and core-3 Ϫ/Ϫ mice as described elsewhere (10) and determined the status of NF-B following CR infection.
As shown in Fig. 5A , NF-B activity increased significantly in CLPs isolated from CR-infected distal colon compared with uninfected controls, and the activity did not decline in CLPs isolated from CR-infected DBZ-treated colons. This led to significant increases in CXCL-1 expression in CR-infected DBZ-treated samples vs. untreated CR-infected samples, while CXCL-1 expression in uninfected controls was low (Fig. 5Aii) . These changes were associated with significant increases in relative levels of cellular and nuclear p65 276 (Fig. 5Bi ) and p65 536 (Fig. 5Bii) , respectively. In core-3 Ϫ/Ϫ mice, similar increases in NF-B activity (Fig. 5Ci) , p65 phosphorylation at Ser 276 , and p65 276 expression (Fig. 5Cii) were recorded, while changes in p65 276 were less obvious (Fig. 5Ciii) . We showed previously that DBZ almost completely inhibited the generation of NICD and Hes-1 in the crypt, resulting in an upregulation of Math-1 (1). However, these changes were less obvious in DBZ-treated CLP, as CR infection and DBZ treatment failed to block NICD (data not shown) or Hes-1, while Math-1 increased significantly in CR-infected DBZ-treated vs. CRinfected untreated samples (Fig. 5D) , suggesting that the lack of effect on NICD or Hes-1 was not necessarily due to nonavailability of DBZ in the CLP or administration of a less effective dose. To determine if alterations in NF-B activity in the CLP led to changes in recruitment of immune cells to the mucosa, we next measured MPO activity as the global marker of leukocyte accumulation. Compared with the uninfected control, MPO activity measured in the purified CLP or in whole distal colon from infected mice increased significantly, suggesting a predominant contribution from the stromal cells (Fig. 5E) . In response to CR infection and DBZ treatment, we observed an exacerbation of MPO activity, which coincided with increases in CXCL-1/KC expression (Fig. 5E) . In addition to changes in MPO activity, we also recorded significant alterations in the recruitment of CD3 ϩ T cells and F4/80 ϩ macrophages in the CLP of NIH Swiss and core-3 Ϫ/Ϫ mice in response to CR infection, which were exacerbated, with the exception of CD3 staining in core-3 Ϫ/Ϫ mice, following DBZ administration (Fig. 5F ).
To determine whether these immune cells were indeed positive for the active form of NF-B, we next stained the paraffin-embedded sections prepared from the distal colons as well as from the CLP with antibody for the p65 276 subunit. As shown in Fig. 6 , increases in p65 276 staining in the colonic crypts of CR-infected NIH Swiss and core-3 Ϫ/Ϫ mice compared with uninfected mice were significantly inhibited following DBZ administration. Since colitis induced by CR infection and DBZ treatment in NIH Swiss or core-3 Ϫ/Ϫ mice is associated with a significant expansion of CD3 ϩ T cells (Fig. 5F ), we next determined if Notch-NF-B cross talk exists in Rag-1 Ϫ/Ϫ mice lacking mature B and T cells. The colonic sections, as well as the CLP, prepared from the uninfected or CR-infected and CR-infected DBZ-treated mice were stained for p65 276 . Interestingly and similar to the other strains, p65 276 staining in the crypt of Rag-1 Ϫ/Ϫ mice increased significantly in response to CR, while it was inhibited by DBZ (Fig. 6 ). In the CLP, p65 276 staining was indiscernible from that recorded in NIH Swiss or core-3 Ϫ/Ϫ mice (Fig. 6 ). Thus, while T cells may be relevant in the context of promoting the inflammatory cascade, they do not seem to be the trigger to initiate colitis induced by CR infection and DBZ treatment (1) . As a readout for changes in NF-B activity, we next examined the cytokine/chemokine profile in the whole distal colon or CLP to determine how alterations in NF-B activity in response to CR infection or CR infection ϩ DBZ treatment affected expression and/or distribution of these proteins. As shown in Fig. 7 , CR infection alone was associated with increases in granulocyte colony-stimulating factor (G-CSF), macrophage inflammatory protein (MIP)-1␤, and regulated and normal T cell expressed and presumably secreted (RANTES) in whole tissues, while IL-1␤, IFN␥, KC, MIP-1, and eotaxin were upregulated in the CLP. In response to CR infection and DBZ treatment, IFN␥, G-CSF, KC, monocyte chemoattractant protein 1 (MCP-1), and IFN␥-induced protein (IP)-10 were upregulated in the whole tissue, while IL-1␣, IL-1␤, KC, and IP-10 were significantly upregulated in the CLP (Fig. 7) . The lack of decrease in cytokine/chemokine levels in the CLP in response to chronic Notch inhibition may be attributed to lack of inhibition of NF-B activity in the CLP, while the whole tissue data apparently reflect the stromal response, with little contribution from the epithelium. This may explain why we did not observe significant inhibition of cyto- kine/chemokine expression in the whole tissue in response to CR infection and DBZ treatment.
Effect of dietary intervention on Notch-NF-B cross talk.
We next examined the effect of dietary intervention on the modulation of Notch-NF-B cross talk in the two compartments. During the investigation, we observed significant restoration of NF-B signaling with a 4% bael extract or a 4% curcumin diet, as revealed by increases in NF-B activity (Fig. 8A) , CXCL-1 expression (Fig. 8B) , and cellular and nuclear levels of p65 276 (Fig. 8C) and p65 536 (Fig. 8D) . Changes in subunit expression were also confirmed immunohistochemically by staining for p65 276 (Fig. 8E) . These increases in NF-B signaling in diettreated colons further blocked apoptosis induced by CR infection ϩ DBZ treatment, as revealed by terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling, thereby promoting crypt regeneration (Fig. 8F) . When the effect of dietary intervention on cytokine/chemokine expression in the colon of NIH Swiss mice was investigated, bael extract, curcumin, or a combination diet blocked increases in IL-1␣/␤, G-CSF, MCP-1, and CXCL-1/KC (data not shown). Importantly, none of these diets had an inhibitory effect on bacterial binding or infectivity (10) . Thus, dietary intervention is a novel mechanism to regulate the Notch-NF-B cross talk in response to bacterial infection.
DISCUSSION
The aim of the current study was to determine the interplay between the Notch and NF-B pathways during TMCH and how this cross talk regulates colonic crypt hyperplasia and/or inflammation following bacterial infection. As an evolutionarily conserved pathway, Notch signaling controls various aspects of tissue development and homeostasis (3). In addition, immunological and inflammation-related studies have provided evidence that Notch signaling regulates NF-B activity during mature T-cell activation or thymocyte development (25) . It is also conceivable, however, that other cell types, such as intestinal epithelial cells (IECs), in conjunction with cells of the immune system, may exhibit similar cross talk, thereby regulating the host's response to an enteric pathogen. This possibility was explored in the current study. Results of our study provide experimental evidence that a Notch-NF-B cross talk exists and that signaling via these pathways in communication with cells of epithelial and stromal origin dictates hyperplasia and/or inflammation or tumorigenesis as disease outcomes.
We showed recently that a cross talk exists between Wnt/ ␤-catenin and the Notch pathway in colonic crypts and that inhibiting the Notch pathway chronically leads to severe inflammation and colitis in otherwise inflammation-resistant NIH Swiss mice (1). In the current study, we extend this observation by systematically analyzing the interplay between the Notch and NF-B pathways in various genetic strains. Interestingly, we recorded a stage dependency in terms of NF-B regulation by the Notch pathway, wherein acute inhibition of Notch signaling did not have an effect on NF-B activity, while chronic inhibition completely abrogated NF-B signaling, suggesting that NF-B is downstream from the Notch pathway. This is not unprecedented. In a recent study, Schwarzer et al. (31) showed that Notch is an essential upstream regulator of NF-B and is relevant for survival of Hodgkin and Reed-Sternberg cells. Similarly, Notch-1 was recently shown to upregulate LPS-induced macrophage activation (19) . Ironically and as suggested by Osipo et al. (25) , Notch-NF-B cross talk has predominantly been studied in Tor B-cell development or during leukemia. In the context of the intestine, a recent study by Sodhi et al. (34) showed that signals via the LPS receptor TLR4 and Notch are increased in intestinal tissues of patients with necrotizing enterocolitis and are required for induction of necrotizing enterocolitis. Using transgenic mice overexpressing progastrin [fatty acid-binding protein-progastrin (Fabp-PG)], we showed previously that goblet cell hyperplasia in Fabp-PG mice was abrogated by inhibitors of NF-B signaling, suggesting a cross talk between the NF-B and Notch pathways (29) . In the current study, we observed Notch-NF-B interplay in NIH Swiss, as well as core-3 Ϫ/Ϫ , mice, which are defective in intestinal mucin (2), and in Apc Min/ϩ mice, which develop adenomas in the distal colon in response to CR infection (24) . Interestingly, while chronic inhibition of Notch signaling in NIH Swiss or core-3 Ϫ/Ϫ mice led to significant barrier disruption and colitis, as reported earlier (1), similar intervention in Apc Min/ϩ mice may have attenuated the progression of adenomatosis by blocking NF-B signaling. While this is consistent with earlier reports of conversion of proliferative cells in the Apc Min/ϩ tumor to postmitotic goblet cells by DBZ, the results of our study indicate a complex scenario, wherein thorough investigation of the NF-B signaling must be included in a protocol that is to be used to manipulate the Notch pathway for experimental or therapeutic purposes. These results further demonstrate that the Notch-NF-B cross talk, associated with distinct (e.g., G-CSF, IFN␥, KC, and MCP-1), as well as overlapping (e.g., IL-1␣/␤, MIP␤, and KC), expression of cytokines and chemokines in the epithelial and stromal compartments, plays an important role in promoting hyperplasia and/or inflammation in response to bacterial infection. Moreover, these studies reiterate the notion that whether the signals for expression of proinflammatory cytokines or chemokines have a stromal or an epithelial origin, they reflect a continuous cross talk between these compartments for the maintenance of normal gut epithelium.
In general, IECs respond to invasive pathogens by expressing proinflammatory cytokines and chemokines (15) . This programming of epithelial cells to produce proinflammatory molecules leads to attraction and transepithelial migration of polymorphonuclear leukocytes, thereby disrupting the permeability of the epithelium (17) . At the same time, however, direct interaction of Salmonella with the epithelial cells without internalization is shown to be sufficient for triggering transepithelial migration of polymorphonuclear leukocytes (12) . In the case of CR, which is noninvasive, we showed previously in an inbred C3H/HeNsd strain that distinct compartmentalization of NF-B activity in the crypts and the lamina propria regulates crypt hyperplasia and/or colitis (10 , along with total p65, in colonic crypt extracts from groups described in A determined by Western blotting. E and F: paraffin-embedded sections from distal colons of groups described in A stained with antibody specific for p65 276 (E) or subjected to terminal deoxynucleotidyl transferase dUTP-mediated nick-end labeling (TUNEL) assay to detect apoptosis (F). Values (means Ϯ SE from 3 independent experiments) represent percentage of cells positive for p65 276 (E) and percentage of TUNEL-positive cells (F). Scale bars, 50 m (E) and 75 m (F).
patients could be attributed to lack of regenerative ability of the epithelial cells, the mechanism is far from clear. Notch signaling acts as a gatekeeper of the gut progenitor compartment and has been shown recently to play an essential role in the containment of intestinal inflammation (41) . Its role in tissue regeneration following intestinal damage, however, is less well understood. Results of our study clearly suggest that Notch signaling works in tandem with components of the NF-B pathway to regulate IEC-immune cell interaction in response to a pathogenic insult, which may be critical in dictating whether the outcome will be more severe intestinal injury or whether the gut will undergo a regenerative process. The importance of the activated immune cells of the lamina propria in IBD was shown in studies that examined the effect of TNF-blocking antibodies that inhibited IEC apoptosis and restored barrier function in patients with Crohn's disease, whereas these antibodies induced apoptosis of lamina propria mononuclear cells, which contributed to resolution of the inflammatory response (40) . Other investigations clearly established a role for NF-B in IBD, as pharmacological inhibition of NF-B had protective effects in mouse models of colitis (16) . Despite these advances, our results suggest a caveat for an interventional approach, since the stroma can offer significant resistance to anti-inflammatory approaches, probably due to sustained activation of NF-B in the CLP. Thus a balanced approach is apparently required to target the interplay between the Notch and NF-B pathways for the development of novel strategies to treat inflammatory diseases.
We showed previously that dietary intervention via 6% pectin or 4% curcumin differentially regulates NF-B activity in the crypt and CLP in mice of various genetic backgrounds (10, 38) . We also showed recently that dietary bael and curcumin modulated the Notch and Wnt/␤-catenin cross talk and ameliorated colitis in response to CR infection and DBZ treatment (25) . In the current study, we investigated the effect of dietary intervention on the modulation of the interplay between the Notch and NF-B pathways in the two compartments. Interestingly, bael-and curcumin-containing diets exhibited differential responses to block increases in lymphocytes/macrophages and proinflammatory cytokines/chemokines, on the one hand, and to facilitate crypt regeneration by blocking crypt cell apoptosis induced by CR infection and DBZ treatment, on the other. Since environmental risk factors, including dietary factors, and not just genetic susceptibility are critical in the pathogenesis of IBD, our studies further add to this debate by providing experimental evidence for dietary modulation of Notch and NF-B cross talk in vivo, which is in agreement with our previous reports that described the effect of dietary bael, curcumin, and pectin intervention on mucus production or mucosal regeneration, leading to amelioration of colitis (1, 10, 38) .
In conclusion, functional cross talk exists between the Notch and NF-B pathways during TMCH, and blocking NF-B activity in the colonic crypts alone is not sufficient to ameliorate inflammation and/or colitis mediated probably by sustained NF-B activation in the CLP. While dietary intervention is a novel approach to target the Notch-NF-B cross talk, development of small-molecule inhibitors that target stromal NF-B, and not necessarily the Notch blockers, may also be an excellent alternative from a therapeutic strategy standpoint to mitigate inflammation and/or colitis following bacterial infection.
